Trial Profile
An Open-label, Single-dose Study to Determine the Metabolism and Excretion of [14C]E2006 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Lemborexant (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 03 Nov 2020 Results published in the Drug Metabolism and Disposition
- 15 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2014 Planned end date changed from 1 May 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov.